Fundraising Fox
Variantyx
Framingham, US · Founded 2014 · Delaware corporation · 219 employees on LinkedIn · 9 known investors
Find your way into Variantyx
Sign up to see every warm intro you have to Variantyx
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Variantyx team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Variantyx is a molecular diagnostics company offering genetic testing for rare genetic disorders, reproductive genetics, and precision oncology. It serves healthcare providers using proprietary laboratory technology and AI/ML analytical tools for genomic testing and personalized medicine.
Founders & leadership
Variantyx was founded in 2014 by Haim Neerman and Tomer Jackman.
Board
Investors · 9
How we know: 20/20 HealthCare Partners LLC's portfolio page · the company's own site · funding news · Not right? Tell us
How we know: Bosch Ventures's portfolio page · the company's own site · finance.yahoo.com · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: the company's own site · funding news · insideprecisionmedicine.com · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: OrbiMed's portfolio page · the company's own site · the VCSheet dataset · Not right? Tell us
How we know: Peregrine Ventures's portfolio page · the company's own site · funding news · finance.yahoo.com · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: the company's own site · finance.yahoo.com · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: the company's own site · Not right? Tell us
Funding
SEC filings, press & company announcements$51.6M disclosed across 2 of 3 rounds · 2021–2024
- $36MraisedApr 2024 · 3 sources
Bosch Ventures, New Era Capital Partners, Peregrine Ventures, Pitango HealthTech
Source ↗ - Undisclosed amountSeries CFeb 2022
New Era Capital partners (lead)
Source ↗
▶$15.6MraisedMar 2021 · 8 investors · Other TechnologyRule 506(b)
- Zafrira AvnurDirector
- Hillel BachrachDirector
- Noam ShomronDirector
- Greg FaustDirector
- Haim NeermanExecutive Officer, Director
- Offering amount
- $20.1M
- Amount sold
- $15.6M
- First sale
- Feb 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 7
Companies working in the same space as Variantyx.
In the news
Frequently asked questions
- What does Variantyx do?
- Variantyx is a molecular diagnostics company offering genetic testing for rare genetic disorders, reproductive genetics, and precision oncology. It serves healthcare providers using proprietary laboratory technology and AI/ML analytical tools for genomic testing and personalized medicine.
- Who founded Variantyx?
- Variantyx was founded by Haim Neerman, Tomer Jackman in 2014.
- Who are Variantyx's investors?
- Variantyx's investors include 20/20 HealthCare Partners LLC, Bosch Ventures, New Era Capital Partners, OrbiMed, Peregrine Ventures, Pitango, Quark Venture Inc., Soleus Capital and 1 more.
- How much funding has Variantyx raised?
- Variantyx has disclosed $51.6M raised across 2 of its 3 known rounds.
- Where is Variantyx headquartered?
- Variantyx is headquartered in Framingham, US.